title: Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Ikuo
authors.initials: I
authors.lastname: Aoki
authors.forename: Takaaki
authors.initials: T
authors.lastname: Ishine
authors.forename: John J
authors.initials: JJ
authors.lastname: Renger
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Winrow
authors.forename: Satoru
authors.initials: S
authors.lastname: Hisada
mesh_terms: D000818:Animals; D001381:Azepines / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D000068796:Orexin Receptor Antagonists / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D000068776:Sleep Aids, Pharmaceutical / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000503:physiopathology; D014230:Triazoles / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D001381:Azepines; D000068796:Orexin Receptor Antagonists; D000068776:Sleep Aids, Pharmaceutical; D014230:Triazoles; C551624:suvorexant